The associations between TP53 rs1042522, MDM2 rs2279744, rs3730485, and MDM4 rs4245739 variants and the clinical features of AML patients are illustrated as Supplementary Materials (Supplementary Materials Tables S1–S4. This evidence concerns the gene TP53 and acute myeloid leukemia.